Between a ROC and a Hard Place: Using prevalence plots to understand the likely real world performance of biomarkers in the clinic
share
The Receiver Operating Characteristic (ROC) curve and the Area Under the Curve (AUC) of the ROC curve are widely used to compare the performance of diagnostic and prognostic assays. The ROC curve has the advantage that it is independent of disease prevalence. However, in this note we remind readers that the performance of an assay upon translation to the clinic is critically dependent upon that very same prevalence. Without an understanding of prevalence in the test population, even robust bioassays with excellent ROC characteristics may perform poorly in the clinic. Instead, simple plots of candidate assay performance as a function of prevalence rate give a more realistic understanding of the likely real-world performance and a greater understanding of the likely impact of variation in that prevalence on translational performance in the clinic.
READ FULL TEXT
